Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era.

European respiratory review : an official journal of the European Respiratory Society - 30 Jun 2018

Savale Laurent, Guignabert Christophe, Weatherald Jason, Humbert Marc

Abstract excerpt

Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) include different cardiopulmonary disorders in which the interaction of multiple genes with environmental and behavioural factors modulates the onset and the progression of these severe conditions. Although the development of therapeutic agents that modulate abnormalities in three major pathobiological pathways for PAH has revolutionised our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Arterial Pressure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Hypertension, Pulmonary

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Pulmonary Artery

Source

Open in PubMed Open full text

Identifiers

PMID: 29653948
DOI: 10.1183/16000617.0004-2018
PMCID: PMC9488842

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era.PMID 29653948Read ↗

Personalised medicine in interstitial lung diseases: Number 6 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.Semantic proximity Read ↗

Genetics and pharmacogenomics in pulmonary arterial hypertension.Semantic proximity Read ↗

Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.Semantic proximity Read ↗

[Advances in genome-wide association study of pulmonary arterial hypertension].Semantic proximity Read ↗

[Pulmonary hypertension: Possible genetic causes and therapeutic options].Semantic proximity Read ↗

Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.Semantic proximity Read ↗

Management of Pulmonary Arterial Hypertension. Current Strategies and Future ProspectsSemantic proximity Read ↗

Genetics and precision genomics approaches to pulmonary hypertension.Semantic proximity Read ↗

Exploring the pathogenesis of pulmonary vascular diseaseSemantic proximity Read ↗

Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertensionSemantic proximity Read ↗

Idiopathic pulmonary arterial hypertension.Semantic proximity Read ↗

Recent advances in pulmonary arterial hypertensionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.